Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches
Top-Down approaches have an extremely high biological relevance, especially when it comes to biomarker discovery, but the necessary pre-fractionation constraints are not easily compatible with the robustness requirements and the size of clinical sample cohorts. We have demonstrated that intact prote...
Main Authors: | Jerome Vialaret, Pierre-Olivier Schmit, Sylvain Lehmann, Audrey Gabelle, Jason Wood, Marshall Bern, Rainer Paape, Detlev Suckau, Gary Kruppa, Christophe Hirtz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340918303275 |
Similar Items
-
Complex Proteoform Identification Using Top-Down Mass Spectrometry
by: Kou, Qiang
Published: (2019) -
Chapter Preparing Proteoforms of Therapeutic Proteins for Top-Down Mass Spectrometry
by: Heikaus, Laura
Published: (2019) -
Protamine Characterization by Top-Down Proteomics: Boosting Proteoform Identification with DBSCAN
by: Gianluca Arauz-Garofalo, et al.
Published: (2021-04-01) -
Chapter Preparing Proteoforms of Therapeutic Proteins for Top-Down Mass Spectrometry
Published: (2019) -
Profiling Dopamine-Induced Oxidized Proteoforms of β-synuclein by Top-Down Mass Spectrometry
by: Arianna Luise, et al.
Published: (2021-06-01)